News from the MCRC
Director's Update
25/03/2022
On Cancer Westminster Launch
On 3 March 2022, to mark the launch of On Cancer, Policy@Manchester organised a panel discussion in Westminster to spotlight the policy recommendations that could help improve the lives of patients impacted by cancer.
MCRC Blog
24/03/2022
The ALETHEIA framework in radiation oncology
Dr Marianne Aznar explains the ALETHEIA Framework, an AI toolkit developed by Rolls-Royce, and how it is being applied to radiation oncology
MCRC Blog
16/03/2022
MCRC-DCS Alumni Showcase
Manchester Cancer Research Centre and Division of Cancer Sciences clinical and non-clinical PhD alumni discuss their post-PhD career highlights and tips for current postgraduate researchers.
Partner News
14/03/2022
New era for Kenyan healthcare begins
Director's Update
04/03/2022
MCRC Director’s Update – February 2022
TARGET National, Stampede, and DETERMINE clinical trials, as well as activities from World Cancer Day and Equality Diversity and Inclusivity cap off February at the MCRC.
Researcher Stories
02/03/2022
Thomas Kedward
Director's Update
04/02/2022
Introducing On Cancer
Professor Rob Bristow outlines the importance of the On Cancer publication and engagement of policy makers alongside our unique research and technologies here in Manchester.
Researcher Stories
17/01/2022
Hadiyat Ogunlayi
Research Spotlight
05/01/2022
Cancer researchers across the UK join forces to find drugs for rare cancers
DETERMINE is the first UK national precision medicine trial in rare cancers, testing a range of therapies specifically targeting key genetic changes in cancer cells.
MCRC Blog
17/12/2021
Cancer Revolution: Science, Innovation and Hope
Director's Update
16/12/2021
MCRC Director’s Update – December 2021
At the end of 2021, we look back and reflect on the some of our major accomplishments and challenges of the past year, and a look ahead to 2022.
Director's Update
29/11/2021
MCRC Director’s Update – November 2021
Researcher Stories
23/11/2021
Madeleine Strach
We speak to Madeleine Strach about rare cancers and her work with The Christie Colorectal and Peritoneal Oncology Centre (CPOC) research group on appendix cancer.
MCRC Blog
19/11/2021
ACES (Alternative Cervical Screening): Acceptability of a urine self-test for cervical screening in the LGBTQ+ population
The LBTM+ ACES project aims to explore the acceptability of a non-invasive, self-taken urine screening test for cervical screening in the LB and TM population, which has the potential to increase the number of individuals screened and narrow the health inequality gap.